Paradigm Biopharmaceuticals | PAR - Pre Tax Profit

Stock Price
0.26
Daily Change
-0.01 -3.70%
Monthly
-21.21%
Yearly
-46.94%
Q1 Forecast
0.27

Paradigm Biopharmaceuticals reported -642K in Pre-Tax Profit for its fiscal semester ending in June of 2025.





Pre Tax Profit Change Date
Avita Medical AUD -23.77M 12.2M Jun/2025
Medical Developments International AUD -149K 466K Jun/2025
Neuren Pharmaceuticals AUD 9.86M 161.24M Jun/2025
Pacific Edge NZD -714K 49K Mar/2024
PYC Therapeutics AUD -12.57M 13.3M Jun/2025
Telix Pharmaceuticals AUD 76.73M 66.04M Jun/2025